Cargando…
Progress in the treatment of solid tumors with apatinib: a systematic review
With the investigation of molecular targets, many agents, such as trastuzumab and ramucirumab, have attained a positive outcome in oncotherapy. Vascular endothelial growth factor (VEGF) is considered a potent factor in angiogenesis and plays an important role in the growth of tumors. Moreover, both...
Autores principales: | Zhao, Deze, Hou, Helei, Zhang, Xiaochun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056166/ https://www.ncbi.nlm.nih.gov/pubmed/30050305 http://dx.doi.org/10.2147/OTT.S172305 |
Ejemplares similares
-
The efficacy and safety of apatinib for refractory malignancies: a review and meta-analysis
por: Sun, Dantong, et al.
Publicado: (2018) -
The role of RICTOR amplification in targeted therapy and drug resistance
por: Zhao, Deze, et al.
Publicado: (2020) -
Apatinib suppresses cell growth and metastasis and promotes antitumor activity of temozolomide in glioma
por: Wang, Chao, et al.
Publicado: (2018) -
Treatment-related toxicities of apatinib in solid tumors: a meta-analysis
por: Peng, Ling, et al.
Publicado: (2018) -
Response to apatinib in chemotherapy-failed advanced spindle cell breast carcinoma
por: Zhou, Na, et al.
Publicado: (2016)